Results 191 to 200 of about 19,419,888 (317)
Contemporary data-driven innovations in peptide-based therapeutic design. [PDF]
Priyadarsinee L +5 more
europepmc +1 more source
Both cg12821679MAPRE3 methylation and MAPRE3 expression are significantly associated with overall survival (OS) of non‐small cell lung cancer. Meanwhile, MAPRE3 expression significantly modified the effect of smoking cessation on OS. Smoking cessation benefits OS merely for patients with high MAPRE3 expression.
Chao Chen +14 more
wiley +1 more source
FUSE: data-driven functional segmentation of DNA methylation data. [PDF]
Holmström S +5 more
europepmc +1 more source
Radiotherapy (RT) response depends on the DNA repair capacity of tumor and host cells. We show that circulating tumor cell (CTC) counts and apoptosis rates before and after RT predict treatment response and outcome, which can be accessed via easily accessible liquid biopsy approaches. Created in BioRender. Wikman, H.
Yvonne Goy +10 more
wiley +1 more source
Data driven drift correction for complex optical systems. [PDF]
Mishra A +6 more
europepmc +1 more source
A urine‐based digital PCR assay targeting two hotspot TERT promoter variants detected bladder cancer with high sensitivity and no false positives in this case–control cohort. The streamlined AbsoluteQ workflow outperformed Sanger sequencing and supports non‐invasive molecular testing for bladder cancer detection.
Anna Nykel +12 more
wiley +1 more source
Information-Theoretic Security and Privacy in Modern Data-Driven Systems. [PDF]
Seif M, Sun H.
europepmc +1 more source
Data-Driven C-Refinement A proof-of-concept
This poster was presented at the IUTAM Symposium on Data-driven mechanics, taking place in Paris, France in Octoboer 2022. It shows a proof-of-concept for a new application of Data-Driven Computational Mechanics (DDCM): using it as a new type of adaptive
Wattel, Sacha +2 more
core
This study shows that lung adenocarcinomas exploit developmental branching morphogenesis to acquire a therapy resistant basal‐like tumour cell state. This process was found to be regulated by combined TP53 loss‐of‐function and type‐I interferon signalling, identifying a novel axis for biomarker and therapeutic target discovery.
Kamila J Bienkowska +13 more
wiley +1 more source
Improving representativeness in trial recruitment: A data-driven approach. [PDF]
Khajehpour P +6 more
europepmc +1 more source

